HER2-Mutant NSCLC: Closing the Gap Between Detection and Optimal Treatment
Discover what’s next in NSCLC care with a focus on HER2-targeted treatment. Learn when and how to test for HER2 alterations, explore the latest targeted therapies, and gain practical, case-based strategies to move faster from detection to the right treatment.
- Price
- Free
- Accredited provider:
- i3 Health Joint Providership
- Learning platform:
- IQ Apparatus
- Release date
- February 9, 2026
- Expires
- February 8, 2027